Montanaro Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-5,000
Closed -$2.19M 44
2023
Q3
$2.19M Sell
5,000
-10,500
-68% -$5.24M 0.38% 38
2023
Q2
$7.78M Sell
15,500
-39,800
-72% -$19.1M 1.23% 25
2023
Q1
$27.7M Buy
55,300
+8,250
+18% +$3.95M 4.29% 8
2022
Q4
$19.2M Sell
47,050
-750
-2% -$291K 3.12% 15
2022
Q3
$15.6M Sell
47,800
-10,000
-17% -$3.67M 2.38% 22
2022
Q2
$20.3M Buy
57,800
+500
+0.9% +$204K 3.05% 12
2022
Q1
$31.3M Sell
57,300
-350
-0.6% -$184K 3.86% 10
2021
Q4
$38M Buy
57,650
+4,250
+8% +$2.67M 3.83% 10
2021
Q3
$33.2M Sell
53,400
-600
-1% -$403K 4% 8
2021
Q2
$34.1M Hold
54,000
4.29% 9
2021
Q1
$26.4M Sell
54,000
-6,200
-10% -$3.11M 3.89% 9
2020
Q4
$30.1M Buy
+60,200
New +$26.9M 5.08% 8

Other funds holding IDXX

Montanaro Asset Management's IDXX Position: Q4 2023 in Review

Montanaro Asset Management sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 5,000 shares — an estimated $2.19M sold.

Montanaro Asset Management first reported a position in IDXX in Q4 2020 and held it in 12 quarters. The position peaked at $38M in Q4 2021. 1,153 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

  • Montanaro Asset Management reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
  • Montanaro Asset Management sold 5,000 Idexx Laboratories shares in Q4 2023, an estimated $2.19M.
  • Montanaro Asset Management first reported a position in Idexx Laboratories in Q4 2020 and held it in 12 quarters.
  • Montanaro Asset Management's Idexx Laboratories position peaked at $38M in Q4 2021.
  • 1,153 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Montanaro Asset Management's 13F filing for Q4 2023, filed 9 Feb 2024.